Francesco Bifari
Papers
1
Total Citations
6
H-Index
1
About
Francesco Bifari is a clinical researcher whose work centers on novel pharmacological interventions for treatment-resistant psychiatric disorders, with a particular focus on major depressive disorder (MDD) and dissociative symptoms. His major contributions include investigating REL-1017 (esmethadone) as a rapid-acting therapeutic option for patients unresponsive to standard antidepressants, specifically examining its potential to reduce dissociative symptoms—a frequently overlooked yet highly prevalent comorbidity in psychiatric populations. Bifari’s research highlights that while dissociative disorders affect nearly 29% of psychiatric outpatients, fewer than 5% receive a proper diagnosis, underscoring the critical need for targeted treatments. His 2022 study on esmethadone’s effects on dissociative symptoms in MDD patients has garnered attention for addressing this diagnostic and therapeutic gap. With a citation count reflecting growing interest in his work, Bifari is advancing the understanding of how glutamatergic modulation may offer new hope for patients with complex, treatment-resistant presentations, bridging the divide between clinical research and real-world psychiatric care.
Research Focus
Key Achievements
Top Papers
- 1